The Clinical Research, Drug Safety and Pharmacovigilance Post-Graduate Diploma Program is designed to develop specialized knowledge and skills required to; write study protocols, monitor and manage clinical trials, and to conduct drug safety and pharmacovigilance activities. This hands-on training approach includes drafting adverse reaction reports and preparing periodic safety update reports.
The program focuses on the global healthcare system as well as the Canadian healthcare system, Canadian regulatory agencies, health care legislation, international guidelines, and standard operating procedures (SOP). Using practical and current real cases, AAPS integrates a unique approach and provides students with the foundation and practical knowledge to formulate a sound clinical development plan; ensure clinical trial data is credible and accurate; and that the rights, integrity and confidentiality of trial subjects are protected.
A well-trained and knowledgeable Clinical Research and Pharmacovigilance professional plays a vital role in protecting the study participant and the general population for marketed drugs and in helping to reduce the time between drug development and marketing approval. The demand for knowledgeable and trained Clinical Research and Pharmacovigilance professionals continues to grow, as supply is limited.
Graduates of the Clinical Research, Drug Safety and Pharmacovigilance Post-Graduate Diploma Program can pursue careers in the Pharmaceutical, Biotechnological, Medical devices, Cosmetics, Natural health Products, and allied industries.
AAPS graduates have been hired as:
Graduates will receive a Post-Graduate Diploma on Clinical Research, Drug Safety and Pharmacovigilance that is approved by the Ministry of Colleges and Universities. AAPS Graduates will also qualify for Certified Clinical Research Professional - CCRP Certification awarded by Society of Clinical Research Associates (SOCRA).
For more information on benefit of CCRP certification please visit https://www.socra.org/certification